Application of composition in diagnosis of triple negative breast cancer
A composition and technology of breast cancer, applied in the direction of microbial measurement/testing, biochemical equipment and methods, etc., can solve the problems of tracking, not being able to be used as the prognostic effect of breast cancer, and limited diagnostic value of breast cancer, so as to increase the sensitivity of chemotherapy Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] miRNA-specific PCR detection is used, that is, cellular miRNAs are extracted and reverse-transcribed, and then detected by real-time quantitative PCR. For the detection results, see Figure 1-Figure 3 As shown, it was found that the expression levels of miR-141, miR-200a and miR-145 in triple-negative breast cancer cell lines MDA-MB-231, BT-549, SUM1315 and Hs578T were significantly lower than those in Luminal-type MCF7, T47D and BT474 cell lines, as well as HER2-overexpressing SKBR3 cell lines, and HMLE below normal mammary epithelial cells.
Embodiment 2
[0030] After the relevant tissues were taken out from the liquid nitrogen and homogenized, tissue miRNAs were extracted and reverse-transcribed, then detected by real-time quantitative PCR, and 72 pairs of breast cancer tissues paired with cancer and paracancerous normal were detected by miRNA-specific qRT-PCR The expressions of miR-141, miR-200a and miR-145 in (43 cases of Luminal type, 29 cases of triple negative type), the test results can be found in Figure 4 As shown, the results found that compared with the paired adjacent normal tissues, the expression of miR-141, miR-200a and miR-145 in triple-negative breast cancer (TNBC) tissues was significantly lower than that in Luminal breast cancer tissues.
Embodiment 3
[0032] The expression of miR-141, miR-200a and miR-145 in breast cancer tissues was detected by miRNA-specific in situ hybridization (ISH, insituhybridizations, target miRNAs stained blue, and nuclei stained red). For the detection results, see Figure 5 As shown, the results found that compared with normal breast tissue, Luminal A breast cancer tissue, Luminal B breast cancer tissue and HER2-positive breast cancer tissue, miR-141, miR-200a and miR-145 were significantly different in triple-negative breast cancer tissue. The expression was significantly down-regulated in cancer tissues.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com